×
About 883 results

ALLMedicine™ Multicentric Castleman Disease Center

Research & Reviews  435 results

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman...
https://doi.org/10.1182/bloodadvances.2020002801
Blood Advances; Arnautou P, Auclair M et. al.

Mar 31st, 2021 - Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.|2021|Arnautou P,Auclair M,Fellahi S,Bouché C,Fieschi C,|

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993110
Blood Advances; Ramaswami R, Lurain K et. al.

Mar 15th, 2021 - Kaposi sarcoma (KS)-associated herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) is a relapsing and remitting systemic lymphoproliferative disorder characterized by severe inflammatory symptoms most common among people living with...

Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman dise...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937249
Journal of Medical Case Reports; Ferrero S, Ragaini S

Mar 7th, 2021 - Human herpervirus-8/human immunodeficiency virus negative Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disorder sustained by a pro-inflammatory condition of hypercytokinemia mostly mediated by Interleukin-6 (IL-6). Acc...

UCD with MCD-like inflammatory state: surgical excision is highly effective.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805307
Blood Advances; Zhang MY, Jia MN et. al.

Feb 11th, 2021 - Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder presenting as a single nodal mass with characteristic histopathology. Patients with UCD are typically asymptomatic with normal laboratory markers, whereas patients with mult...

Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV...
https://doi.org/10.1177/0956462420968385
International Journal of STD & AIDS; Lin IF, Lin JN et. al.

Feb 8th, 2021 - Coexistence of multicentric Castleman disease and Kaposi sarcoma is rare and might be missed without an experienced pathologists' interpretation. A 46-year-old man had been diagnosed with HIV infection and treated with combination antiretroviral t...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  441 results

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman...
https://doi.org/10.1182/bloodadvances.2020002801
Blood Advances; Arnautou P, Auclair M et. al.

Mar 31st, 2021 - Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.|2021|Arnautou P,Auclair M,Fellahi S,Bouché C,Fieschi C,|

Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993110
Blood Advances; Ramaswami R, Lurain K et. al.

Mar 15th, 2021 - Kaposi sarcoma (KS)-associated herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) is a relapsing and remitting systemic lymphoproliferative disorder characterized by severe inflammatory symptoms most common among people living with...

Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman dise...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937249
Journal of Medical Case Reports; Ferrero S, Ragaini S

Mar 7th, 2021 - Human herpervirus-8/human immunodeficiency virus negative Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disorder sustained by a pro-inflammatory condition of hypercytokinemia mostly mediated by Interleukin-6 (IL-6). Acc...

UCD with MCD-like inflammatory state: surgical excision is highly effective.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805307
Blood Advances; Zhang MY, Jia MN et. al.

Feb 11th, 2021 - Unicentric Castleman disease (UCD) is a rare lymphoproliferative disorder presenting as a single nodal mass with characteristic histopathology. Patients with UCD are typically asymptomatic with normal laboratory markers, whereas patients with mult...

Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV...
https://doi.org/10.1177/0956462420968385
International Journal of STD & AIDS; Lin IF, Lin JN et. al.

Feb 8th, 2021 - Coexistence of multicentric Castleman disease and Kaposi sarcoma is rare and might be missed without an experienced pathologists' interpretation. A 46-year-old man had been diagnosed with HIV infection and treated with combination antiretroviral t...

see more →

News  4 results

New guidelines for idiopathic multicentric Castleman disease
https://www.mdedge.com/hematology-oncology/article/184660/related-issues/new-guidelines-idiopathic-multicentric-castleman-disease
Andrew D. Bowser

Oct 10th, 2018 - Photo from Penn Medicine David C. Fajgenbaum, MD The anti-IL-6 antibody siltuximab is central to first-line treatment of idiopathic multicentric Castleman disease (iMCD), according to new guidelines on iMCD published in Blood.

New guidelines frame treatment options for Castleman disease
https://www.mdedge.com/hematology-oncology/article/175993/patient-survivor-care/new-guidelines-frame-treatment-options
Andrew D. Bowser

Sep 28th, 2018 - The anti-interleukin-6 antibody siltuximab is central to first-line treatment of idiopathic multicentric Castleman disease (MCD), although adjuvant chemotherapy can be critical in severe cases, according to the first-ever consensus treatment guide.

Castleman Disease
https://www.mdedge.com/fedprac/article/102230/lymphoma-plasma-cell-disorders/castleman-disease
Harjot Kaur, MD, Zhifu Xiang, MD, PhD et. al.

Sep 2nd, 2015 - Castleman disease (CD) is a rare nonclonal lymphoproliferative disorder, also known as angiofollicular lymph-node hyperplasia or giant node hyperplasia. It was first reported in 1954 and in 1956 described by Benjamin Castleman, MD, in a case serie.

Valganciclovir Cut Oral Shedding of Herpesvirus 8
https://www.mdedge.com/internalmedicine/article/12699/infectious-diseases/valganciclovir-cut-oral-shedding-herpesvirus-8
Sherry Boschert

SAN FRANCISCO — The first randomized, controlled clinical study of an antiviral medication's effects on human herpesvirus 8 found a 79% reduction in viral shedding in the oropharynx of 26 men taking 900 mg/day of valganciclovir, Dr. Corey Casper r.

see more →

Patient Education  2 results see all →